Marshall Wace
CELL

Marshall Wace’s PhenomeX Inc. Common Stock CELL Stock Holding History

Marshall Wace’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-31,797
Closed -$85.2K – 3347
2022
Q4 		$85.2K Buy
+31,797
New +$83.8K ﹤0.01% 2807
2022
Q2 		– Sell
-18,832
Closed -$134K – 3994
2022
Q1 		$134K Sell
18,832
-13,923
-43% -$115K ﹤0.01% 3164
2021
Q4 		$595K Sell
32,755
-83,953
-72% -$1.81M ﹤0.01% 2715
2021
Q3 		$2.28M Buy
+116,708
New +$4.44M 0.01% 1456
2021
Q1 		– Sell
-103,059
Closed -$9.21M – 2964
2020
Q4 		$9.21M Buy
+103,059
New +$8.67M 0.05% 372

Other funds holding CELL

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
NIMC
Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Marshall Wace's CELL Position: Q1 2023 in Review

Marshall Wace sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 31,797 shares — an estimated $85.2K sold.

Marshall Wace first reported a position in CELL in Q4 2020 and held it in 5 quarters. The position peaked at $9.21M in Q4 2020. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

  • Marshall Wace reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Marshall Wace sold 31,797 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $85.2K.
  • Marshall Wace first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Marshall Wace's PhenomeX Inc. Common Stock position peaked at $9.21M in Q4 2020.
  • 102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.